Historical record - last NADAC effective date: 9/20/2023
Product Information
DOXEPIN HCL 6 MG TABLET is a generic product labeled by Currax Pharmaceuticals LLC, priced at $6.6863 per EA under NDC 44183010630. Its NADAC has been published 180 times since Apr 22, 2020.
FDA first approved this application on Mar 17, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxepin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/1
Manufacturer
Currax Pharmaceuticals LLCNDC
44183010630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/20/2023
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022036FDA Approved
3/17/2010
TE Code
AB
On Market Since
8/1/2010
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 6 MG TABLET has been published 180 times since Apr 22, 2020, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6863 per EA |
|---|---|
| All-time high | $10.5934 (Jun 10, 2020) |
| All-time low | $6.0192 (Aug 23, 2023) |
| Median price | $8.2996 |
| Average price | $8.3689 |
| Largest weekly change | -23.9% (Aug 23, 2023) |
| Weeks tracked | 180 |
| Tracking since | Apr 22, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-15.5%
5Y
-20.5%
All
-29.5%
Last surveyed Sep 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 6 MG TABLET, manufactured by Currax Pharmaceuticals LLC, is $6.6863 per EA (NDC 44183010630), effective Sep 27, 2023.
How has the price of DOXEPIN HCL 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 6 MG TABLET has declined 29.5%. It has been tracked across 180 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 6 MG TABLET?
Since Apr 22, 2020, the NADAC for DOXEPIN HCL 6 MG TABLET has ranged from a low of $6.0192 (Aug 23, 2023) to a high of $10.5934 (Jun 10, 2020), with a median of $8.2996 per EA.
Are there cheaper alternatives to DOXEPIN HCL 6 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN HCL 6 MG TABLET, is $1.4446 per EA — about 78% below DOXEPIN HCL 6 MG TABLET.
Who manufactures DOXEPIN HCL 6 MG TABLET?
DOXEPIN HCL 6 MG TABLET (NDC 44183010630) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a generic product.